<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">.lst-kix_h7q861bamhh5-3>li:before{content:"-  "}.lst-kix_h7q861bamhh5-5>li:before{content:"-  "}ul.lst-kix_nfs8zrb2j9km-0{list-style-type:none}ul.lst-kix_nfs8zrb2j9km-2{list-style-type:none}ul.lst-kix_pz52pfg595p-8{list-style-type:none}ul.lst-kix_nfs8zrb2j9km-1{list-style-type:none}.lst-kix_h7q861bamhh5-4>li:before{content:"-  "}.lst-kix_h7q861bamhh5-8>li:before{content:"-  "}ul.lst-kix_nfs8zrb2j9km-4{list-style-type:none}ul.lst-kix_pz52pfg595p-6{list-style-type:none}ul.lst-kix_nfs8zrb2j9km-3{list-style-type:none}ul.lst-kix_pz52pfg595p-7{list-style-type:none}ul.lst-kix_nfs8zrb2j9km-6{list-style-type:none}ul.lst-kix_pz52pfg595p-4{list-style-type:none}ul.lst-kix_nfs8zrb2j9km-5{list-style-type:none}.lst-kix_h7q861bamhh5-1>li:before{content:"-  "}ul.lst-kix_pz52pfg595p-5{list-style-type:none}ul.lst-kix_nfs8zrb2j9km-8{list-style-type:none}.lst-kix_m57640kwgas6-4>li:before{content:"-  "}ul.lst-kix_pz52pfg595p-2{list-style-type:none}ul.lst-kix_nfs8zrb2j9km-7{list-style-type:none}ul.lst-kix_pz52pfg595p-3{list-style-type:none}.lst-kix_m57640kwgas6-5>li:before{content:"-  "}ul.lst-kix_pz52pfg595p-0{list-style-type:none}.lst-kix_h7q861bamhh5-2>li:before{content:"-  "}ul.lst-kix_pz52pfg595p-1{list-style-type:none}.lst-kix_m57640kwgas6-6>li:before{content:"-  "}ul.lst-kix_h7q861bamhh5-0{list-style-type:none}.lst-kix_m57640kwgas6-7>li:before{content:"-  "}ul.lst-kix_h7q861bamhh5-3{list-style-type:none}ul.lst-kix_h7q861bamhh5-4{list-style-type:none}ul.lst-kix_h7q861bamhh5-1{list-style-type:none}ul.lst-kix_h7q861bamhh5-2{list-style-type:none}.lst-kix_h7q861bamhh5-7>li:before{content:"-  "}ul.lst-kix_h7q861bamhh5-7{list-style-type:none}.lst-kix_m57640kwgas6-8>li:before{content:"-  "}ul.lst-kix_h7q861bamhh5-8{list-style-type:none}ul.lst-kix_h7q861bamhh5-5{list-style-type:none}.lst-kix_h7q861bamhh5-6>li:before{content:"-  "}ul.lst-kix_h7q861bamhh5-6{list-style-type:none}ul.lst-kix_m57640kwgas6-0{list-style-type:none}.lst-kix_pz52pfg595p-8>li:before{content:"\0025a0  "}ul.lst-kix_m57640kwgas6-3{list-style-type:none}ul.lst-kix_m57640kwgas6-4{list-style-type:none}ul.lst-kix_m57640kwgas6-1{list-style-type:none}ul.lst-kix_m57640kwgas6-2{list-style-type:none}.lst-kix_pz52pfg595p-6>li:before{content:"\0025cf  "}.lst-kix_pz52pfg595p-7>li:before{content:"\0025cb  "}.lst-kix_pz52pfg595p-0>li:before{content:"\0025cf  "}.lst-kix_pz52pfg595p-2>li:before{content:"\0025a0  "}.lst-kix_m57640kwgas6-3>li:before{content:"-  "}.lst-kix_pz52pfg595p-1>li:before{content:"\0025cb  "}.lst-kix_pz52pfg595p-5>li:before{content:"\0025a0  "}.lst-kix_m57640kwgas6-2>li:before{content:"-  "}ul.lst-kix_m57640kwgas6-7{list-style-type:none}ul.lst-kix_m57640kwgas6-8{list-style-type:none}ul.lst-kix_m57640kwgas6-5{list-style-type:none}ul.lst-kix_m57640kwgas6-6{list-style-type:none}.lst-kix_pz52pfg595p-4>li:before{content:"\0025cb  "}.lst-kix_m57640kwgas6-0>li:before{content:"-  "}.lst-kix_m57640kwgas6-1>li:before{content:"-  "}.lst-kix_pz52pfg595p-3>li:before{content:"\0025cf  "}.lst-kix_nfs8zrb2j9km-1>li:before{content:"-  "}.lst-kix_nfs8zrb2j9km-0>li:before{content:"-  "}.lst-kix_8wtesurhy0s5-5>li:before{content:"-  "}.lst-kix_nfs8zrb2j9km-5>li:before{content:"-  "}.lst-kix_nfs8zrb2j9km-4>li:before{content:"-  "}.lst-kix_nfs8zrb2j9km-6>li:before{content:"-  "}.lst-kix_8wtesurhy0s5-3>li:before{content:"-  "}.lst-kix_8wtesurhy0s5-7>li:before{content:"-  "}ul.lst-kix_8wtesurhy0s5-8{list-style-type:none}.lst-kix_8wtesurhy0s5-4>li:before{content:"-  "}.lst-kix_8wtesurhy0s5-8>li:before{content:"-  "}ul.lst-kix_8wtesurhy0s5-4{list-style-type:none}ul.lst-kix_8wtesurhy0s5-5{list-style-type:none}ul.lst-kix_8wtesurhy0s5-6{list-style-type:none}.lst-kix_nfs8zrb2j9km-2>li:before{content:"-  "}ul.lst-kix_8wtesurhy0s5-7{list-style-type:none}ul.lst-kix_8wtesurhy0s5-0{list-style-type:none}.lst-kix_nfs8zrb2j9km-3>li:before{content:"-  "}ul.lst-kix_8wtesurhy0s5-1{list-style-type:none}ul.lst-kix_8wtesurhy0s5-2{list-style-type:none}.lst-kix_8wtesurhy0s5-6>li:before{content:"-  "}ul.lst-kix_8wtesurhy0s5-3{list-style-type:none}.lst-kix_8wtesurhy0s5-0>li:before{content:"-  "}.lst-kix_h7q861bamhh5-0>li:before{content:"-  "}.lst-kix_8wtesurhy0s5-1>li:before{content:"-  "}.lst-kix_nfs8zrb2j9km-8>li:before{content:"-  "}.lst-kix_nfs8zrb2j9km-7>li:before{content:"-  "}.lst-kix_8wtesurhy0s5-2>li:before{content:"-  "}ol{margin:0;padding:0}table td,table th{padding:0}.c7{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:162pt;border-top-color:#000000;border-bottom-style:solid}.c4{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:156pt;border-top-color:#000000;border-bottom-style:solid}.c13{border-right-style:solid;padding:5pt 5pt 5pt 5pt;border-bottom-color:#000000;border-top-width:1pt;border-right-width:1pt;border-left-color:#000000;vertical-align:top;border-right-color:#000000;border-left-width:1pt;border-top-style:solid;border-left-style:solid;border-bottom-width:1pt;width:155.2pt;border-top-color:#000000;border-bottom-style:solid}.c5{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left;height:11pt}.c2{color:#000000;font-weight:700;text-decoration:none;font-size:11pt;font-family:"Arial";font-style:normal}.c8{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c18{padding-top:12pt;padding-bottom:12pt;line-height:1.15;orphans:2;widows:2;text-align:justify}.c3{color:#000000;font-weight:400;text-decoration:none;font-size:11pt;font-family:"Arial";font-style:normal}.c14{color:#000000;font-weight:400;text-decoration:none;font-size:11pt;font-family:"Arial";font-style:italic}.c24{border-spacing:0;border-collapse:collapse;margin-right:auto}.c1{padding-top:0pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c25{text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;text-decoration:underline}.c21{margin-left:36pt;text-indent:-36pt;height:11pt}.c20{margin-left:58.5pt;text-indent:-58.5pt}.c15{padding:0;margin:0}.c17{margin-left:25.2pt;text-indent:-25.2pt}.c6{color:inherit;text-decoration:inherit}.c9{margin-left:36pt;padding-left:0pt}.c26{max-width:468pt;padding:72pt 72pt 72pt 72pt}.c22{margin-left:19.2pt;text-indent:-19.2pt}.c23{height:11pt}.c10{background-color:#ffffff}.c12{vertical-align:super}.c19{font-weight:700}.c11{height:0pt}.c0{vertical-align:baseline}.c16{font-style:italic}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:20pt;color:#000000;font-size:20pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c10 c26"><p class="c8"><span class="c2 c0">Effectiveness of airport screening at detecting travellers infected with 2019-nCoV</span></p><p class="c5"><span class="c2 c0"></span></p><p class="c5"><span class="c2 c0"></span></p><p class="c8 c20"><span class="c16">Authors</span><span>: Billy Quilty</span><span class="c12">1</span><span>, Sam Clifford</span><span class="c12">1</span><span>, CMMID nCoV working group, Stefan Flasche</span><span class="c12">1*</span><span>, Rosalind Eggo</span><span class="c12">1*</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8 c20"><span class="c16">Affiliations</span><span>: </span><span class="c12">1</span><span class="c3 c0">Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span class="c16">Keywords</span><span class="c3 c0">: 2019-nCoV, airport screening, effectiveness, thermal scanning, emerging infections, interventions, surveillance</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span class="c16">Note: this report is a pre-print and has not yet been peer-reviewed.</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span class="c16">Key messages</span></p><ul class="c15 lst-kix_pz52pfg595p-0 start"><li class="c8 c9"><span class="c3 c0">As the number of novel coronavirus cases grows both inside and outside of China, public health authorities require evidence on the effectiveness of control measures such as thermal screening of arrivals at airports. </span></li><li class="c8 c9"><span class="c3 c0">We evaluated the effectiveness of exit and entry screening for 2019-nCoV infection. In our baseline scenario, we estimated that 63.4% (95%CI: 51.9 to 74.6) of infected travellers would not be detected, depending on the incubation period, sensitivity of exit and entry screening, and the proportion of cases which are asymptomatic. </span></li><li class="c8 c9"><span>Airport screening is unlikely to detect </span><span>a sufficient</span><span class="c3 c0">&nbsp;proportion of 2019-nCoV infected travellers to avoid entry of infected travellers.</span></li><li class="c8 c9"><span>We developed an online tool so that results can be updated as new information becomes available.</span></li></ul><p class="c5"><span class="c14 c0"></span></p><p class="c5"><span class="c14 c0"></span></p><p class="c8"><span class="c16">Background</span><span><br>As of </span><span>27 Jan 2019</span><span>,</span><span>&nbsp;2,741 </span><span>confirmed and 5741 suspected cases of 2019-nCoV have been reported from China with 80 deaths confirmed so far </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?TXGUwV&amp;sa=D&amp;ust=1580248794682000">1</a></span><span>. There were cases in at least 9 othe</span><span>r countries, identified due to symptoms plus recent travel history to Hubei Province, China, which strongly suggests that the reported cases constitute only a small fraction of the actual number of infected individuals in </span><span>China </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?4utxxE&amp;sa=D&amp;ust=1580248794683000">2</a></span><span>. While the most affected region, Hubei province, has now ceased air travel and closed major public transport routes </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?FP1WWQ&amp;sa=D&amp;ust=1580248794683000">3</a></span><span class="c3 c0">&nbsp;it is unlikely that these measures will fully contain the outbreak. </span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span>Despite limited evidence for its effectiveness </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?2nc1g4&amp;sa=D&amp;ust=1580248794683000">4,5</a></span><span class="c3 c0">, airport screening is frequently implemented to limit the probability of infected cases entering other regions or countries. Here we use the available evidence to evaluate the effectiveness of exit and entry screening for detecting travellers with 2019-nCoV. We also provide an online app so that results can be updated as new information becomes available.</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span class="c14 c0">Simulation of travellers at each stage of infection</span></p><p class="c8"><span>We simulated 100 infected air travellers who are still infected with 2019-nCoV on arrival at their destination and hence would pose a risk for seeding transmission in a new region. The duration of travel is</span><span>&nbsp;the flight time plus a small amount of additional travel </span><span>time </span><span>for airport procedures</span><span>.</span><span>&nbsp;We assumed that most individuals will develop symptoms, including fever, at the end of their incubation period and progress to more severe symptoms after a few days, resulting in hospitalisation and isolation. </span><span>Individuals may also exhibit an asymptomatic (subclinical) infection where they do not exhibit symptoms that would be detected by thermal scanning</span><span>&nbsp;or cause them to seek medical care, although these individuals may be infectious. </span><span>Travellers may exhibit severe symptoms during their travel; upon arrival they are hospitalised without undergoing entry screening</span><span>. </span><span class="c3 c0">We then estimated the proportion of travellers who would be detected by exit and entry screening, develop severe symptoms during travel, or go undetected, under varying assumptions of: </span></p><ul class="c15 lst-kix_nfs8zrb2j9km-0 start"><li class="c8 c9"><span class="c3 c0">the proportion of asymptomatic infections; </span></li><li class="c8 c9"><span class="c3 c0">the sensitivity of exit and entry screening; </span></li><li class="c8 c9"><span class="c3 c0">the duration of travel; </span></li><li class="c8 c9"><span class="c3 c0">the incubation period;</span></li><li class="c8 c9"><span>the time from the start of symptoms until hospitalisation (Table 1).</span></li></ul><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span>We assume that the time of starting travel i</span><span>s </span><span>randomly</span><span>&nbsp;and uniformly distributed between the time of infection and twice the expected time </span><span>to severe disease; however, </span><span>we only consider those travellers who depart before their symptoms worsen to the point that they would seek hospital care </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?ZVUFl4&amp;sa=D&amp;ust=1580248794686000">6</a></span><span>. We simulate travellers with individual incubation period, time from onset to severe disease, flight start times and detection success at exit and entry screening according to the screening sensitivities (Figure 3).</span><span>&nbsp;</span><span>W</span><span>e consider only the travel of infected individuals (not the proportion of travellers who are infected) and therefore assume a screening specificity of 100%</span><span>. </span><span>An individual will be detected at exit screening if their infection is not asymptomatic, their departure time exceeds their incubation period, and </span><span>their stochastic exit screening success </span><span>indicates detection</span><span>.</span><span>&nbsp;</span><span>An individual will be detected at entry screening if their infection is not asymptomatic, their incubation period ends after their departure but before their arrival, they have not been detected at exit screening, </span><span>and the</span><span>ir entry screening success indicates detection</span><span>.</span><span class="c3 c0">&nbsp;Entry screening detections are further divided into detection due to severe symptoms and detection of mild symptoms via equipment such as thermal scanners. We used 10,000 bootstrap samples to calculate 95% confidence intervals.</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span>The model code is available via GitHub </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?tlEcRS&amp;sa=D&amp;ust=1580248794687000">7</a></span><span>&nbsp;and the results</span><span>&nbsp;can be further explored in an R Shiny app at </span><span class="c25"><a class="c6" href="https://www.google.com/url?q=https://cmmid-lshtm.shinyapps.io/traveller_screening/&amp;sa=D&amp;ust=1580248794687000">https://cmmid-lshtm.shinyapps.io/traveller_screening/</a></span><span>&nbsp;(Figure 1).</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span class="c3 c0">Table 1: Parameter values and assumptions for the baseline scenario</span></p><a id="t.2870885abb2517325d2985398f4c4941a27eb6c7"></a><a id="t.0"></a><table class="c24"><tbody><tr class="c11"><td class="c4" colspan="1" rowspan="1"><p class="c1"><span class="c19">P</span><span class="c2 c0">arameter</span></p></td><td class="c7" colspan="1" rowspan="1"><p class="c1"><span class="c2 c0">Value (baseline scenario)</span></p></td><td class="c13" colspan="1" rowspan="1"><p class="c1"><span class="c0 c2">Source</span></p></td></tr><tr class="c11"><td class="c4" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Travel time</span></p></td><td class="c7" colspan="1" rowspan="1"><p class="c1"><span>1</span><span>2 hours</span></p></td><td class="c13" colspan="1" rowspan="1"><p class="c1"><span>Beijing - London </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?eQ3EkB&amp;sa=D&amp;ust=1580248794691000">8</a></span></p></td></tr><tr class="c11"><td class="c4" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Sensitivity of exit screening</span></p></td><td class="c7" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">86%</span></p></td><td class="c13" colspan="1" rowspan="1"><p class="c1"><span>86% for </span><span class="c10">Infrared thermal image scanners </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?R2lltQ&amp;sa=D&amp;ust=1580248794692000">9</a></span></p></td></tr><tr class="c11"><td class="c4" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Sensitivity of entry screening</span></p></td><td class="c7" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">86%</span></p></td><td class="c13" colspan="1" rowspan="1"><p class="c1"><span>86% for </span><span class="c10">Infrared thermal image scanners </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?zIrgB7&amp;sa=D&amp;ust=1580248794693000">9</a></span></p></td></tr><tr class="c11"><td class="c4" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Proportion of asymptomatic infections undetectable by typical screening procedures</span></p></td><td class="c7" colspan="1" rowspan="1"><p class="c1"><span>17%</span></p></td><td class="c13" colspan="1" rowspan="1"><p class="c1"><span>1 of 6 reported asymptomatic in a 2019-nCoV family cluster </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?mx5N0R&amp;sa=D&amp;ust=1580248794695000">10</a></span></p></td></tr><tr class="c11"><td class="c4" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Incubation period</span></p></td><td class="c7" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Gamma distributed, mean 6.36 days, variance 16.67 days</span></p></td><td class="c13" colspan="1" rowspan="1"><p class="c8"><span>SARS-like </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?it0Hp1&amp;sa=D&amp;ust=1580248794697000">11</a></span></p></td></tr><tr class="c11"><td class="c4" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Time from symptom onset to hospitalisation</span></p></td><td class="c7" colspan="1" rowspan="1"><p class="c1"><span class="c3 c0">Gamma distributed, mean 3.8 days, variance 6.0 days</span></p></td><td class="c13" colspan="1" rowspan="1"><p class="c8"><span>SARS-like </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?owhOw6&amp;sa=D&amp;ust=1580248794700000">11</a></span></p></td></tr></tbody></table><p class="c5"><span class="c14 c0"></span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span class="c14 c0">Effect of screening on detection</span></p><p class="c8"><span>For the baseline scenario we </span><span>estimated that 28 (95%CI: 18-39) of 100 infected </span><span>travellers</span><span class="c3 c0">&nbsp;would be detected by exit screening, 1 (95% CI: 0-4) case would develop severe symptoms during travel, 8 (95%CI: 2-15) cases would be detected by entry screening, &nbsp;and the remaining 63 (95%CI: 52-75) would not be detected. </span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span>Syndromic screening designed to prevent infected and potentially infectious cases entering undetected is highly vulnerable to asymptomatic infections and long incubation periods. If the baseline scenario is modified to have 0% asymptomatic infections and 100% sensitivity of entry screening, </span><span>the incubation period will need to be approximately 10-fold shorter than the period from symptom onset to </span><span>severe disease (e.g. hospitalisation) in order to detect more than 90% of infected travellers that would not otherwise </span><span>report illness</span><span class="c3 c0">&nbsp;at either exit or entry screening. </span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span>The effectiveness of entry screening is largely dependent on the effectiveness of exit screening in place. Under baseline assumptions, entry screening could detect 36</span><span>&nbsp;(95%CI: </span><span>19-54</span><span>)</span><span>&nbsp;instead of 8 infected travellers if no exit screening was in place. However, the probability of developing symptoms mid-flight increases with flight time and hence exit screening is more effective for longer flights (Figure 2).</span></p><p class="c5"><span class="c3 c0"></span></p><p class="c8"><span class="c14 c0">Conclusions</span></p><p class="c8"><span class="c16">A</span><span class="c3 c0">s a response to the ongoing outbreak of a novel coronavirus originating in Wuhan, the Chinese government has implemented exit screening for international flights leaving China&rsquo;s major airports. Thermal scanning, which can identify passengers with fever (high external body temperature), allows for passengers exhibiting symptoms of 2019-nCoV infection to be tested before they board a flight. Similarly, entry screening for flights originating in the most affected regions may be considered at airports in regions in and outside China. We estimate that the key goal of syndromic screening at airports - to prevent infected travellers from entering regions with little or no ongoing transmission - is only achievable if the rate of asymptomatic infections that are transmissible is negligible, screening sensitivity is almost perfect, and the incubation period is short. We find that this is unlikely to be the case if 2019-nCoV has a similar incubation period as SARS and particularly so if asymptomatic infections are frequent and infectious. Under generally conservative assumptions we find that 63.4% of infected travellers will enter undetected.</span></p><p class="c18"><span>Entry screening is an intuitive barrier for the prevention of infections entering a region or country. However, evidence on its effectiveness is </span><span>limited and given the lack of specificity, it generates a high </span><span>overhead of screened travellers uninfected with the targeted </span><span>pathogen </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?9VeHns&amp;sa=D&amp;ust=1580248794704000">4</a></span><span>. For example, w</span><span>hen entry screening was implemented in Australia in response to the 2003 SARS outbreak, 1.84 million people were screened, 794 were detained, and no cases were confirmed </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?QocxvM&amp;sa=D&amp;ust=1580248794704000">12</a></span><span>.</span><span class="c3 c0">&nbsp;While some cases of 2019-nCoV have been identified through airport screening in the current outbreak we estimate that likely many more infected travellers have passed through screening undetected.</span></p><p class="c18"><span>It is important to note that our estimates are based on a number of key assumptions that cannot yet be informed directly by evidence from the ongoing 2019-nCoV outbreak. The current outbreak has spread rapidly and early evidence suggests that the average severity is lower than &nbsp;</span><span>SARS.</span><span>&nbsp;This may also suggest a substantial proportion of asymptomatic cases. A recent analysis of a family transmission cluster is based on a small sample size but 1 in 6 infections was a</span><span>symptomatic </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?0KUOFN&amp;sa=D&amp;ust=1580248794705000">10</a></span><span class="c3 c0">; a major impediment for the effectiveness of syndromic screening. However, if asymptomatic cases were not infectious they would not pose a risk for seeding infection chains on arrival. To allow easy adaptation of our results as new insight becomes available in the coming weeks we developed an online app.</span></p><p class="c18"><span class="c3 c0">Furthermore, neither the incubation period or the time until recovery has been well characterised for 2019-nCoV yet. We have used estimates derived for SARS but also show that unless the incubation period is only a small fraction of the duration of clinical symptoms, and fever in particular, syndromic screening is likely to detect an insufficient fraction of infected cases to prevent local infections. Similarly, the sensitivity of airport screening for the detection of 2019-nCoV has not been evaluated. However, we chose conservative estimates and show that with reduced sensitivity the effectiveness of syndromic screening would further decline.</span></p><p class="c18"><span>In many international airports,</span><span>&nbsp;</span><span>information is provided </span><span>to</span><span>&nbsp;travellers from affected regions advising recommended action if they develop symptoms </span><span>on or after arrival </span><span class="c12"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?bRb9q0&amp;sa=D&amp;ust=1580248794707000">13&ndash;16</a></span><span>. While this is likely to be an effective strategy, we find that airport screening for initial symptoms, via thermal scanners or similar, on either exit or entry is unlikely to detect </span><span>a sufficient</span><span>&nbsp;proportion of 2019-nCoV infected travellers in order to avoid entry of infected travellers and therefore the potential for </span><span>seeding of local transmission</span><span class="c3 c0">.</span></p><p class="c1 c21"><span class="c3 c0"></span></p><p class="c1 c21"><span class="c3 c0"></span></p><p class="c1"><span class="c16">References</span></p><p class="c1 c22"><span>Available from: </span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794708000">1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;World Health Organisation. Novel Coronavirus (2019-nCoV) Situation Report-7 [Internet]. 2020 Jan. Report No.: 76. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov.pdf?sfvrsn=98ef79f5_2</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794709000">2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Imperial College London. News / Wuhan Coronavirus [Internet]. MRC Centre for Global Infectious Disease Analysis: News / Wuhan Coronavirus. 2020 [cited 2020 Jan 27]. Available from: http://www.imperial.ac.uk/medicine/departments/school-public-health/infectious-disease-epidemiology/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794709000">3. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coronavirus Spurs China to Suspend Tours Abroad and Xi to Warn of a &lsquo;Grave Situation&rsquo;. The New York Times [Internet]. 2020 Jan 25 [cited 2020 Jan 27]; Available from: https://www.nytimes.com/2020/01/25/world/asia/china-coronavirus.html</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794709000">4. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gostic KM, Kucharski AJ, Lloyd-Smith JO. Effectiveness of traveller screening for emerging pathogens is shaped by epidemiology and natural history of infection. eLife [Internet]. [cited 2020 Jan 27];4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337724/</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794710000">5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mabey D, Flasche S, Edmunds WJ. Airport screening for Ebola. BMJ [Internet]. 2014 Oct 14 [cited 2020 Jan 28];349. Available from: https://www.bmj.com/content/349/bmj.g6202</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794710000">6. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pitman RJ, Cooper BS, Trotter CL, Gay NJ, Edmunds WJ. Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ. 2005 Nov 24;331(7527):1242&ndash;3.</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794711000">7. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Traveller Screening GitHub Repository. https://github.com/bquilty25/airport_screening;</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794711000">8. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;British Airways - Timetables [Internet]. [cited 2020 Jan 27]. Available from: https://www.britishairways.com/travel/schedules/public/en_gb</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794711000">9. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Priest PC, Duncan AR, Jennings LC, Baker MG. Thermal Image Scanning for Influenza Border Screening: Results of an Airport Screening Study. PLoS ONE [Internet]. 2011 Jan 5 [cited 2020 Jan 27];6(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016318/</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794712000">10. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet [Internet]. 2020 Jan 24 [cited 2020 Jan 27];0(0). Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30154-9/abstract</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794712000">11. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. The Lancet. 2003 May 24;361(9371):1761&ndash;6.</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794712000">12. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Samaan G, Patel M, Spencer J, Roberts L. Border screening for SARS in Australia: what has been learnt? Med J Aust. 2004 Mar 1;180(5):220&ndash;3.</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794713000">13. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CNN BKC. Airport screenings for the Wuhan coronavirus increase around the world [Internet]. CNN. [cited 2020 Jan 27]. Available from: https://www.cnn.com/travel/article/coronavirus-airport-screenings/index.html</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794713000">14. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Passengers arriving from Wuhan, China are being screened for the novel coronavirus | San Francisco International Airport [Internet]. FlySFO | San Francisco International Airport. [cited 2020 Jan 27]. Available from: https://www.flysfo.com/passengers-arriving-wuhan-china-are-being-screened-novel-coronavirus</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794714000">15. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Department of Health. https://www.gov.uk/guidance/wuhan-novel-coronavirus-information-for-the-public#advice-for-travellers-from-wuhan.</a></span></p><p class="c1 c17"><span class="c0"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?CMtO94&amp;sa=D&amp;ust=1580248794714000">16. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DiGiovanni C, Conley J, Chiu D, Zaborski J. Factors Influencing Compliance with Quarantine in Toronto During the 2003 SARS Outbreak. Biosecurity Bioterrorism Biodefense Strategy Pract Sci. 2004 Dec;2(4):265&ndash;72.</a></span></p><p class="c1 c17 c23"><span class="c3 c0"></span></p><p class="c1 c17 c23"><span class="c3 c0"></span></p><p class="c8"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 624.00px; height: 607.34px;"><img alt="" src="images/image3.png" style="width: 624.00px; height: 607.34px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c8"><span class="c16">Figure 1: Screenshot of app </span><span class="c12 c16"><a class="c6" href="https://www.google.com/url?q=https://www.zotero.org/google-docs/?EIincN&amp;sa=D&amp;ust=1580248794715000">7</a></span><span class="c14 c0">&nbsp;displaying the number of infected travellers detected for the baseline assumptions (Table 1) and the time distributions for incubation period and time to severe disease e.g hospitalisation. Results are from stochastic simulation, and so there may be small variations in the number of travellers in each group when the same parameters are used twice. Sliders are provided to modify the duration of travel, the sensitivity of both exit and entry screening, the proportion symptomatic, and the natural history parameters for the infection.</span></p><p class="c5"><span class="c14 c0"></span></p><p class="c8"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 624.00px; height: 445.33px;"><img alt="" src="images/image2.png" style="width: 624.00px; height: 445.33px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c8"><span class="c14 c0">Figure 2: Probability of detecting infected travellers at entry screening for varying travel durations and sensitivities of exit screening. Each cell is a mean of 10,000 model simulations. Other parameters (Incubation period, symptom onset to hospitalisation period, and asymptomatic rate) were fixed at baseline assumptions (Table 1). Intervals are probabilities of detection, binned at increments of 5% (0-5%, 5-10%, etc.).</span></p><p class="c5"><span class="c14 c0"></span></p><p class="c8"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 624.00px; height: 356.00px;"><img alt="" src="images/image1.png" style="width: 624.00px; height: 356.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c5"><span class="c14 c0"></span></p><p class="c8"><span class="c0 c14">Figure 3: Simulated infection histories of infected travellers. The latent period begins on infection and travellers then progress to symptomatic and severe symptoms. Travellers may fly at any point within the latent or symptomatic phases; any would-be travellers who show severe symptoms are hospitalised prior to exit. Vertical lines represent the exit screening at start of travel (solid) and entry screening at end of travel (dashed) 12 hours later.</span></p></body></html>